These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells. Deuse T; Stubbendorff M; Tang-Quan K; Phillips N; Kay MA; Eiermann T; Phan TT; Volk HD; Reichenspurner H; Robbins RC; Schrepfer S Cell Transplant; 2011; 20(5):655-67. PubMed ID: 21054940 [TBL] [Abstract][Full Text] [Related]
3. Immune characterization of mesenchymal stem cells in human umbilical cord Wharton's jelly and derived cartilage cells. Liu S; Yuan M; Hou K; Zhang L; Zheng X; Zhao B; Sui X; Xu W; Lu S; Guo Q Cell Immunol; 2012; 278(1-2):35-44. PubMed ID: 23121974 [TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy. Wang Q; Yang Q; Wang Z; Tong H; Ma L; Zhang Y; Shan F; Meng Y; Yuan Z Hum Vaccin Immunother; 2016; 12(1):85-96. PubMed ID: 26186552 [TBL] [Abstract][Full Text] [Related]
6. Soluble factors-mediated immunomodulatory effects of canine adipose tissue-derived mesenchymal stem cells. Kang JW; Kang KS; Koo HC; Park JR; Choi EW; Park YH Stem Cells Dev; 2008 Aug; 17(4):681-93. PubMed ID: 18717642 [TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive properties of human umbilical cord-derived mesenchymal stem cells: role of B7-H1 and IDO. Tipnis S; Viswanathan C; Majumdar AS Immunol Cell Biol; 2010; 88(8):795-806. PubMed ID: 20386557 [TBL] [Abstract][Full Text] [Related]
8. Allorecognition of human neural stem cells by peripheral blood lymphocytes despite low expression of MHC molecules: role of TGF-beta in modulating proliferation. Ubiali F; Nava S; Nessi V; Frigerio S; Parati E; Bernasconi P; Mantegazza R; Baggi F Int Immunol; 2007 Sep; 19(9):1063-74. PubMed ID: 17660500 [TBL] [Abstract][Full Text] [Related]
9. Characterization of HLA-G and Related Immunosuppressive Effects in Human Umbilical Cord Stroma-Derived Stem Cells. Ding DC; Chou HL; Chang YH; Hung WT; Liu HW; Chu TY Cell Transplant; 2016; 25(2):217-28. PubMed ID: 26044082 [TBL] [Abstract][Full Text] [Related]
10. Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2. Kim HS; Shin TH; Lee BC; Yu KR; Seo Y; Lee S; Seo MS; Hong IS; Choi SW; Seo KW; Núñez G; Park JH; Kang KS Gastroenterology; 2013 Dec; 145(6):1392-403.e1-8. PubMed ID: 23973922 [TBL] [Abstract][Full Text] [Related]
12. Xenotransplantation of interferon-gamma-pretreated clumps of a human mesenchymal stem cell/extracellular matrix complex induces mouse calvarial bone regeneration. Takeshita K; Motoike S; Kajiya M; Komatsu N; Takewaki M; Ouhara K; Iwata T; Takeda K; Mizuno N; Fujita T; Kurihara H Stem Cell Res Ther; 2017 Apr; 8(1):101. PubMed ID: 28446226 [TBL] [Abstract][Full Text] [Related]
13. Human Wharton's Jelly-Derived Stem Cells Display Immunomodulatory Properties and Transiently Improve Rat Experimental Autoimmune Encephalomyelitis. Donders R; Vanheusden M; Bogie JF; Ravanidis S; Thewissen K; Stinissen P; Gyselaers W; Hendriks JJ; Hellings N Cell Transplant; 2015; 24(10):2077-98. PubMed ID: 25310756 [TBL] [Abstract][Full Text] [Related]
14. Preconditioning with interleukin-1 beta and interferon-gamma enhances the efficacy of human umbilical cord blood-derived mesenchymal stem cells-based therapy via enhancing prostaglandin E2 secretion and indoleamine 2,3-dioxygenase activity in dextran sulfate sodium-induced colitis. Yu Y; Yoo SM; Park HH; Baek SY; Kim YJ; Lee S; Kim YL; Seo KW; Kang KS J Tissue Eng Regen Med; 2019 Oct; 13(10):1792-1804. PubMed ID: 31293088 [TBL] [Abstract][Full Text] [Related]
15. Insensitivity of Human iPS Cells-Derived Mesenchymal Stem Cells to Interferon-γ-induced HLA Expression Potentiates Repair Efficiency of Hind Limb Ischemia in Immune Humanized NOD Scid Gamma Mice. Sun YQ; Zhang Y; Li X; Deng MX; Gao WX; Yao Y; Chiu SM; Liang X; Gao F; Chan CW; Tse HF; Shi J; Fu QL; Lian Q Stem Cells; 2015 Dec; 33(12):3452-67. PubMed ID: 26175298 [TBL] [Abstract][Full Text] [Related]
16. Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Yoo KH; Jang IK; Lee MW; Kim HE; Yang MS; Eom Y; Lee JE; Kim YJ; Yang SK; Jung HL; Sung KW; Kim CW; Koo HH Cell Immunol; 2009; 259(2):150-6. PubMed ID: 19608159 [TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive properties of mesenchymal stromal cells derived from amnion, placenta, Wharton's jelly and umbilical cord. Manochantr S; U-pratya Y; Kheolamai P; Rojphisan S; Chayosumrit M; Tantrawatpan C; Supokawej A; Issaragrisil S Intern Med J; 2013 Apr; 43(4):430-9. PubMed ID: 23176558 [TBL] [Abstract][Full Text] [Related]
18. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients. Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608 [TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory properties of mesenchymal stem cells derived from dental pulp and dental follicle are susceptible to activation by toll-like receptor agonists. Tomic S; Djokic J; Vasilijic S; Vucevic D; Todorovic V; Supic G; Colic M Stem Cells Dev; 2011 Apr; 20(4):695-708. PubMed ID: 20731536 [TBL] [Abstract][Full Text] [Related]
20. Immunological properties of umbilical cord blood-derived mesenchymal stromal cells. Oh W; Kim DS; Yang YS; Lee JK Cell Immunol; 2008 Feb; 251(2):116-23. PubMed ID: 18495100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]